PATENT CLAIM ANALYSIS

Application Number: 16199905
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "114000"]

Abstract:
S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial days of treatment the daily dosage is lower than the standard daily dosage.

Claim (Index 2):
A method of administering to a subject in need thereof a medicament comprising a S1P receptor modulator or agonist for the treatment of a long chronic disease, wherein said S1P receptor modulator or agonist is administered at a daily dosage which is lower than the standard daily therapeutic dosage of said S1P receptor modulator or agonist during an initial period of treatment and then the therapeutic dosage is increased to the standard daily therapeutic dosage of said S1P receptor modulator or agonist.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 98.0
- Lexical Diversity: 1.20833
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12655049', '14732013', '14322722', '15986992', '15534929']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7534798443054188
- 35 USC 102 Novelty (BERT): 0.551378148299374
- Combined Prediction Score: 0.7332696747048143
- Mean Citation Score: 288.4315200000001
- Max Citation Score: 407.60342
- Similarity Product: 387.7692755483747

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test